IL-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2674-2680

  Berg, D J ^a   Zhang, J ^a   Lauricella, D M ^a   Moore, S A ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN INDUCTION; SPLEEN CELL;

EID: 0035865329     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2674     Document Type: Article

References (64)

1. Cyclooxygenase in biology and disease
2. The discovery and function of COX-2
3. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
4. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
5. Nitric oxide synthase and cyclooxygenases: Distribution, regulation, and intervention in arthritis
6. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease
7. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
8. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ
9. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells
10. Selective expression of mitogen-inducible cyclooxygenase in macrophages with lipopolysaccharide
11. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase
12. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages
13. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines
14. Interleukin-1α and tumour necrosis factor-α modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: Inhibition by dexamethasone and fluticasone propionate
15. Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages
16. 2 production by IFN-γ in human macrophages
17. Regulation of cyclooxygenase-2 by interferon γ and transforming growth factor α in normal human epidermal keratinocytes and squamous carcinoma cells: Role of mitogen-activated protein kinases
18. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils
19. Regulation of cyclooxygenase-2 expression in human mesangial cells: Transcriptional inhibition by IL-13
20. 2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: Distinct targeting in the signaling pathways
21. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: Its underlying mechanism in comparison with interleukin-4
22. Synergistic induction of cyclooxygenase-2 by transforming growth factor-β1 and epidermal growth factor inhibits apoptosis in epithelial cells
23. TGF-β 1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS 10/prostaglandin synthase 2 gene in murine macrophages
24. Interleukin-10 inhibits cytokine synthesis by human monocytes: An auto-regulatory role of IL-10 produced by monocytes
25. IL-10 inhibits cytokine production by activated macrophages
26. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
27. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity
28. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
29. Interleukin-10-deficient mice develop chronic enterocolitis
30. + TH1-like responses
31. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene
32. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice
33. Analysis of gene expression by multi-probe RNase protection assay
34. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages
35. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α and lipopolysaccharide
36. Interactions of nitric oxide with cyclooxygenase: In vitro, ex vivo, and in vivo studies
37. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs
38. Structure of the human cyclo-oxygenase-2 gene
39. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-κB activation in J774 macrophages
40. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β
41. In vivo suppression of NF-κB and preservation of 1κBα by interleukin-10 and interleukin-13
42. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
43. mRNA stability in mammalian cells
44. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10
45. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1β and TNF-α
46. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
47. Induction of cyclooxygenase-2 by interleukin-1 α: Evidence for post-transcriptional regulation
48. Interleukin-12: A cytokine at the interface of inflammation and immunity
49. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
50. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation
51. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10
52. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide
53. Nitric oxide: A prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages
54. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
55. Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri
56. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase
57. 2 is a potent inhibitor of human interleukin 12 production
58. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness
59. 2, promote type 2 cytokine production in maturing human naive T helper cells
60. 2
61. 2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice
62. 2 primes naive T cells for the production of anti-inflammatory cytokines
63. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses
64. -/- mice